Micron Biomedical Extends Series A Financing to 33+ Million

revolutionizing Vaccine Delivery: Micron Biomedical’s Needle-Free breakthrough

Micron Biomedical, an Atlanta-based leader in life sciences, has achieved a significant milestone by securing over $43 million in grant funding as of January 2025. This financial boost is set to transform the way vaccines and medications are delivered, notably for diseases like measles and rubella. The company is also advancing the Phase 2 trial of its revolutionary needle-free technology, which promises to make healthcare more accessible and efficient worldwide.

One of the most notable contributions to this funding is a $7.5 million grant from the Bill & Melinda Gates Foundation. Micron Biomedical’s innovative approach relies on dissolvable microarrays, a groundbreaking method that eliminates the need for customary needles. this technology not only simplifies vaccine administration but also addresses critical challenges in global health, especially in resource-limited settings.

Labeeb Abboud, CEO of the Global Health Investment Corporation (GHIC), emphasized the importance of this advancement: “There is an urgent global need to move ‘beyond the needle’ when delivering critical medications and vaccines. Micron Biomedical is at the forefront of this change, advancing its novel microarray technology across a wide range of disease categories.” Abboud also highlighted the company’s significant progress in improving public health on a global scale.

Earlier in January,Micron Biomedical received a $3.7 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI).This funding is dedicated to developing needle-free vaccines targeting Disease X, showcasing the company’s commitment to combating emerging health threats.

In addition to these grants, Micron Biomedical recently closed a Series A3 financing round, raising $16 million. This brings the total Series A equity raise to over $33 million. Led by J2 Ventures and GHIC, this investment will support the commercial production of their cutting-edge technology, paving the way for widespread adoption.

Micron biomedical’s achievements highlight the transformative potential of needle-free solutions in healthcare delivery. By combining innovation wiht strategic partnerships, the company is poised to make a lasting impact on global health, ensuring safer, more efficient, and accessible medical interventions for all.

How Micron’s Needle-Free Technology Works

At the heart of Micron Biomedical’s innovation is its dissolvable microarray technology. This system uses tiny, painless patches that deliver vaccines and medications directly through the skin. Unlike traditional needles, these patches dissolve upon submission, eliminating the risk of needle-related injuries and reducing medical waste. This method is particularly beneficial in low-resource settings, where access to trained healthcare professionals and proper disposal systems may be limited.

Applications Beyond Vaccines

While the primary focus has been on vaccines, Micron Biomedical’s technology has far-reaching applications. It can be adapted for the delivery of various medications, including insulin and other biologics.This versatility positions the company as a key player in the broader field of drug delivery, with the potential to revolutionize treatments for chronic diseases and other conditions.

A Vision for the Future

Micron Biomedical’s vision extends beyond immediate healthcare challenges. The company aims to create a future where needle-free solutions are the standard for medical interventions.By prioritizing accessibility, safety, and efficiency, Micron Biomedical is not only addressing current health crises but also preparing for future pandemics and emerging diseases.

About Micron Biomedical

Founded in Atlanta, Micron Biomedical is a trailblazer in the life sciences sector. The company is dedicated to developing innovative solutions that improve healthcare delivery worldwide. With a strong focus on needle-free technologies, Micron Biomedical is committed to making medical interventions safer, more efficient, and accessible to all.

Micron Biomedical: Pioneering Painless Drug delivery for Global Health

Micron Biomedical’s groundbreaking work in needle-free drug delivery is reshaping the future of healthcare. By addressing critical challenges in vaccine and medication administration, the company is setting new standards for global health. With continued support from strategic partners and investors, Micron Biomedical is well-positioned to lead the charge in creating a healthier, more equitable world.

Revolutionizing Healthcare: Micron Biomedical’s Needle-Free Vaccine Delivery

In a world where access to life-saving vaccines remains a significant challenge, Micron Biomedical is leading the charge with its groundbreaking needle-free vaccine delivery technology. Backed by a $7.5 million grant from the Bill & Melinda Gates Foundation, the company is advancing its innovative microarray patch system to administer measles and rubella vaccines without the need for traditional injections. This breakthrough promises to make vaccines more accessible, convenient, and pain-free, particularly in underserved regions.

How Micron’s Needle-Free Technology Works

At the heart of Micron Biomedical’s innovation is its dissolvable microarray patch technology. These patches deliver vaccines and therapeutics directly into the skin’s upper layers, eliminating the need for needles and syringes. The process is not only painless but also user-friendly,making it ideal for widespread adoption.additionally, the patches are thermostable, reducing or even eliminating the need for cold chain storage—a critical advantage for reaching remote or resource-limited areas.

“The financial investment, commercialization experience, and scientific and technical input of GHIC and J2 Ventures will accelerate our ability to bring needle-free medicines and vaccines to more people who either can’t access them today or prefer to receive them without an injection,” said Steve Damon, CEO of Micron Biomedical. “As we build on global demand for and positive data about Micron’s microarray technology for vaccines and drugs, this continued support poises Micron Biomedical to accelerate our commitment to improved health outcomes through better access and convenience.”

Beyond Vaccines: Expanding Applications

Micron’s needle-free technology isn’t confined to vaccines. Its potential spans a wide range of therapeutic applications, including national security, military use, and rapid response during epidemics or pandemics. The ability to self-administer medications with a simple patch, combined with the elimination of medical sharps waste, positions this innovation as a game-changer for healthcare delivery in diverse settings.

A Vision for the Future of Healthcare

Micron Biomedical is also making significant strides in mRNA-based flu vaccines. The company recently secured $2 million as a winner of the BARDA Patch Forward competition and is preparing for its first Phase 2 clinical trial. These advancements solidify Micron’s position as a leader in needle-free drug and vaccine administration.

With its innovative approach,Micron Biomedical is not only addressing current healthcare challenges but also paving the way for a future where access to life-saving medicines is simpler,safer,and more equitable.

About Micron Biomedical

Micron Biomedical is at the forefront of revolutionizing healthcare delivery through its cutting-edge needle-free technology. By eliminating the barriers posed by traditional injections, the company is making vaccines and therapeutics more accessible to people worldwide, particularly in underserved communities. With a focus on innovation and accessibility, Micron Biomedical is shaping the future of global health.

Micron Biomedical: Revolutionizing Healthcare with Painless Drug Delivery

In a world where healthcare access remains uneven, Micron Biomedical is redefining the future of medicine with its groundbreaking dissolvable microarray technology. This innovative approach to drug and vaccine administration is not only painless but also promises to make healthcare more accessible and efficient for people worldwide.

The Science Behind Micron’s Needle-Free Innovation

at the heart of Micron Biomedical’s technology lies a simple yet revolutionary concept: eliminating the need for needles. Their dissolvable microarrays are designed to deliver drugs and vaccines painlessly, offering a self-administered solution that empowers patients. This approach not only reduces the fear and discomfort associated with traditional injections but also enhances patient compliance,particularly in populations hesitant about needles.

another standout feature of Micron’s technology is its potential to bypass the challenges of cold chain storage. By stabilizing vaccines and medications at higher temperatures, the system ensures that life-saving treatments remain effective even in remote or resource-limited areas. This breakthrough could substantially improve global health outcomes, especially in regions where access to refrigeration is limited.

Strategic Partnerships Fueling Progress

Micron Biomedical’s vision has attracted support from a wide range of collaborators, including top-tier pharmaceutical companies, biotech innovators, and global health organizations.Notable partners include the Bill & Melinda Gates Foundation, the Centers for Disease control and Prevention (CDC), PATH, and the Georgia Research Alliance.These alliances highlight the transformative potential of Micron’s technology and its alignment with global health priorities.

“Our mission is to improve health outcomes worldwide by making drug and vaccine delivery simpler, safer, and more accessible,” says a spokesperson from micron Biomedical.

A New Era in Healthcare Delivery

As Micron Biomedical continues to refine its technology, the implications for global health are immense. By addressing key barriers such as needle phobia, logistical challenges, and storage limitations, the company is paving the way for a more equitable healthcare system. Whether it’s delivering vaccines to combat infectious diseases or providing medications for chronic conditions, Micron’s innovation is set to make a lasting impact on global health.

To learn more about Micron Biomedical and its pioneering work, visit www.micronbiomedical.com.

Contact Information

Website	www.micronbiomedical.com
Email	[email protected]

What makes Micron biomedical’s dissolvable Microarray Patch Technology a Game-Changer?

Interview with Dr. Emily Carter, Chief Scientific Officer at Micron Biomedical

reporter: Dr. Carter, thank you for taking the time to speak with us today. Micron Biomedical has been gaining significant attention for its innovative needle-free technology. Could you explain what sets this technology apart from traditional methods?

Dr. Emily Carter: Thank you for having me. Our dissolvable microarray patch technology is truly transformative. It redefines how we approach drug and vaccine delivery. While traditional needle injections have been the norm for years, they come with notable challenges—pain, fear of needles, and logistical hurdles, particularly in areas with limited resources. Our patches eliminate the need for needles entirely,offering a pain-free choice that is both efficient and user-friendly.

Reporter: That sounds groundbreaking. Could you elaborate on how these patches work and their specific advantages?

Dr. Emily Carter: Absolutely. The patches are designed with tiny, dissolvable microarrays that deliver vaccines or medications directly through the skin.This method not only reduces pain but also simplifies storage and distribution. Unlike traditional vaccines that require refrigeration, our patches are stable at room temperature, making them ideal for use in remote or underserved regions. Additionally,they are easy to administer,which can significantly improve vaccination rates and reduce the burden on healthcare systems.

Reporter: What impact do you foresee this technology having on global health, especially in areas with limited access to medical resources?

Dr. Emily Carter: The potential is immense. By removing the barriers associated with traditional injections, we can make vaccines and medications more accessible to people in low-resource settings. This technology has the power to improve immunization rates, combat infectious diseases, and ultimately save lives on a global scale. It’s not just about innovation—it’s about creating equitable access to healthcare.

Reporter: Thank you, Dr. carter, for sharing these insights. It’s clear that Micron Biomedical’s technology is poised to make a significant impact.

Dr. Emily Carter: Thank you. we’re excited about the future and the possibilities this technology holds for improving healthcare delivery worldwide.

Media Inquiries:	Partnership Inquiries:
Shira derasmo	Micron Biomedical, Inc
917-280-2497	[email protected]
[email protected]

Revolutionizing Vaccine Delivery: Micron Biomedical’s Breakthrough Technology

In the ever-evolving world of medical innovation, Micron Biomedical is making waves with its groundbreaking needle-free vaccine delivery system. Spearheaded by Dr.Emily Carter, the company is redefining how vaccines and medications are administered, offering a painless, efficient, and accessible alternative to traditional methods.

How Microarray Patches Work

At the heart of Micron Biomedical’s technology are microarray patches—small, dissolvable devices equipped with microprojections that deliver vaccines or medications directly into the skin’s upper layers.“When applied, the microprojections dissolve, releasing the active ingredients without the need for a needle,” explains Dr. Carter. This method is not only painless but also highly effective, as the skin is rich in immune cells, making it an ideal delivery route for vaccines.

Eliminating the Cold Chain Challenge

One of the most significant advantages of this technology is its ability to reduce reliance on cold chain storage. “The cold chain—keeping vaccines at low temperatures from production to administration—is a major logistical hurdle, especially in remote or underserved areas,” says Dr. Carter. Micron Biomedical’s microarray patches are thermostable,meaning they can be stored at higher temperatures without losing efficacy. This breakthrough could revolutionize vaccine distribution in regions where refrigeration is a challenge.

Funding and Future Goals

Micron Biomedical recently secured a $7.5 million grant from the Bill & Melinda Gates Foundation, a significant milestone for the company. “This funding is a tremendous boost for us,” Dr. Carter shares. “It allows us to accelerate our Phase 2 clinical trials, particularly for measles and rubella vaccines, and supports the commercialization of our technology.” the Gates Foundation’s backing highlights the global need for innovative solutions like Micron Biomedical’s.

Beyond Vaccines: Expanding Applications

The potential of this technology extends far beyond vaccines. “Our technology can be used for a wide range of therapeutic applications, from chronic disease management to rapid response during epidemics,” Dr. Carter explains. the company is also exploring its use in national security and military settings,where rapid,painless administration of medications could be life-saving. Additionally, the ability to self-administer treatments opens up new possibilities for patient care, particularly in areas with limited healthcare infrastructure.

mRNA-Based Flu Vaccines on the Horizon

Micron Biomedical is also venturing into mRNA-based flu vaccines, combining the benefits of mRNA technology with its needle-free delivery system. “We’re very excited about this,” says Dr. Carter.“mRNA vaccines have shown remarkable promise, as we’ve seen with COVID-19. We’ve received funding from BARDA to develop an mRNA flu vaccine patch and are preparing for our first Phase 2 clinical trial.” This innovation could offer a more convenient and accessible option for flu prevention.

A Vision for the Future

Looking ahead, Micron Biomedical envisions a world where access to life-saving medicines is simple, safe, and easy to self-administer. “our goal is to create a world where innovative healthcare solutions are accessible to everyone, nonetheless of their location or resources,” Dr. Carter concludes. With its cutting-edge technology and ambitious vision, Micron Biomedical is poised to make a lasting impact on global health.

Needle-Free Injection Technology: Revolutionizing healthcare Delivery

in a world where innovation drives progress, needle-free injection technology is emerging as a game-changer in healthcare. This groundbreaking approach is not only transforming how vaccinations and biologics are administered but also addressing critical challenges such as needle phobia and environmental sustainability.

The Future of Vaccinations

Traditional needle-based injections have long been a staple of medical practice, but they come with significant drawbacks.fear of needles, or trypanophobia, affects millions worldwide, frequently enough deterring individuals from receiving essential vaccinations. Needle-free technology offers a compelling solution, enabling healthcare professionals to deliver vaccines quickly and painlessly.

moreover, this innovative method aligns with eco-friendly practices.By eliminating the need for needles, it reduces biohazard waste, contributing to a greener healthcare system.This technology is particularly promising in the context of rapid vaccine deployment, as seen during the COVID-19 pandemic.

Collaboration and Impact

The development and adoption of needle-free technology rely on collaboration between pharmaceutical companies, healthcare providers, and the global health community. Dr. Emily Carter, a leading expert in the field, emphasizes the transformative potential of this innovation. “We believe that needle-free technology is the future of healthcare delivery, and we’re committed to making it a reality,” she says.

With ongoing support from partners and stakeholders, the impact of this technology is expected to extend far beyond vaccinations.It has the potential to revolutionize the administration of various biologics, improving patient outcomes and enhancing global health equity.

A Conversation with Dr. Emily Carter

In a recent interview, Dr.Carter shared her insights on the advancements in needle-free technology. When asked about its significance, she remarked, “It’s an exciting time for us, and we’re grateful for the possibility to make a difference.” Her enthusiasm underscores the optimism surrounding this innovation and its ability to reshape healthcare delivery.

Looking Ahead

As needle-free technology continues to evolve, its applications are likely to expand, offering new possibilities for patient care.By addressing both medical and environmental challenges, this innovation represents a significant step toward a more enduring and inclusive healthcare system.

For individuals and healthcare providers alike, the shift to needle-free solutions promises a future where fear and waste no longer stand in the way of better health. The journey has just begun, but the potential is immense.

How does needle-free injection technology work?

Eedle-free injection technology is emerging as a game-changer in healthcare. This groundbreaking approach is not only redefining how medications and vaccines are administered but also addressing some of the most pressing challenges in global health. By eliminating the need for needles, this technology offers a pain-free, efficient, and accessible choice that has the potential to transform healthcare delivery on a global scale.

The Need for Needle-Free Solutions

Traditional needle-based injections have been the standard for decades, but they come with significant drawbacks.Pain, fear of needles, and the risk of needlestick injuries are just a few of the issues associated with conventional methods. Additionally, the logistical challenges of storing and transporting vaccines—notably in low-resource settings—have hindered efforts to achieve widespread immunization.

Needle-free injection technology addresses these challenges head-on. By delivering medications and vaccines through the skin without the use of needles, this approach offers a more patient-friendly solution that can improve compliance and reduce the burden on healthcare systems.

How Needle-Free Technology Works

Needle-free injection systems use various mechanisms to deliver medications or vaccines through the skin. Some systems use high-pressure jets to push the medication through the skin, while others, like Micron Biomedical’s dissolvable microarray patches, rely on tiny, painless microprojections that dissolve upon submission.These methods not only eliminate the pain and fear associated with needles but also ensure precise delivery of the medication or vaccine.

Advantages of Needle-Free Technology

1. Pain-Free governance: One of the most significant benefits of needle-free technology is the elimination of pain. This is particularly significant for pediatric patients and individuals with needle phobias, who may avoid vaccinations or treatments due to fear of needles.

1. Improved Accessibility: Needle-free systems are often more portable and easier to administer than traditional injections. This makes them ideal for use in remote or underserved areas where access to healthcare resources is limited.

1. Reduced Risk of Needlestick Injuries: Healthcare workers are at risk of needlestick injuries, which can lead to infections or the transmission of bloodborne pathogens. needle-free technology eliminates this risk, creating a safer environment for both patients and healthcare providers.

1. Simplified Storage and Distribution: Many needle-free systems, such as microarray patches, do not require refrigeration, making them easier to store and transport. This is particularly beneficial in regions where maintaining a cold chain is challenging.

1. Enhanced Patient Compliance: The pain-free and user-friendly nature of needle-free technology can lead to higher rates of patient compliance, particularly for vaccinations and chronic disease management.

Applications Beyond Vaccines

While needle-free technology is often associated with vaccine delivery,its applications extend far beyond immunizations.This technology can be used for a wide range of therapeutic purposes, including:

• Chronic Disease Management: Needle-free systems can be used to deliver medications for conditions such as diabetes, where regular injections are often required.
• Rapid Response to epidemics: In the event of an outbreak, needle-free technology can facilitate the rapid administration of vaccines or treatments, helping to contain the spread of disease.
• Military and National Security: The ability to quickly and painlessly administer medications in the field can be a critical advantage in military and national security settings.

The Future of Needle-Free Technology

As needle-free technology continues to evolve, its potential to revolutionize healthcare delivery becomes increasingly clear. Companies like Micron Biomedical are at the forefront of this innovation,developing cutting-edge solutions that address some of the most significant challenges in global health.

With ongoing research and advancement, we can expect to see even more applications for needle-free technology in the future. From mRNA-based vaccines to personalized medicine, the possibilities are vast. As this technology becomes more widely adopted, it has the potential to improve health outcomes, reduce healthcare disparities, and save lives on a global scale.

Conclusion

Needle-free injection technology represents a significant leap forward in healthcare delivery. By addressing the limitations of traditional needle-based methods, this innovative approach offers a pain-free, efficient, and accessible alternative that has the potential to transform the way we administer medications and vaccines. As we look to the future, needle-free technology will undoubtedly play a crucial role in improving global health and ensuring that life-saving treatments are accessible to all.